genuine question about telehealth that I am slightly embarrassed to ask
genuine question about telehealth that I am slightly embarrassed to ask, and I want the answer with the reasoning attached rather than just the conclusion. The five questions worth asking before you commit to any compounded arrangement. Which facility, by name. Whether it is a 503A pharmacy or a 503B outsourcing…
Removed the staff name. Facilities and clinics can be named here; individuals cannot.
Asked for potency testing on the finished preparation. They had it. I had assumed they would not.
if a clinic will not name the facility, that is your answer
do not assume the concentration matches the branded product
I would not read the price difference as a quality signal. Most of it is the consultation model, not the vial.
I would not read the price difference as a quality signal.
Agreed — and the follow-up question is what the beyond-use date is based on.
shortage status changes and the whole arrangement changes with it
compounded is not generic, there is no equivalence claim